Robert Lisicki

Robert Lisicki currently serves as the Chief Executive Officer and President of Zura Bio Limited (Nasdaq: ZURA) since January 2024. Additionally, Robert holds a position on the Board of Directors for Cadrenal Therapeutics, Inc. and Adiso Therapeutics. Previously, Robert was the CEO and a Board Member at InCarda Therapeutics until March 2023, and held the role of Executive Vice President and Chief Commercial Officer at Arena Pharmaceuticals from November 2018 to March 2022, where responsibilities included global scaling and development of novel agents. Other notable positions include General Manager and Vice President at Regeneron, Senior Vice President and Chief Commercial Officer at Daiichi Sankyo, and Vice President and General Manager at Amgen, where Robert contributed to substantial revenue growth and oversight of significant commercial operations. Robert's career began at The Janssen Pharmaceutical Companies of Johnson & Johnson, where Robert was involved in sales and marketing leadership.